Merck KGaA (MRK) Given a 108.00 Price Target by Kepler Capital Markets Analysts

Merck KGaA (MRK) Given a 108.00 Price Target by Kepler Capital Markets Analysts


The brokerage currently has a buy rating on the healthcare company's stock. A number of other equities analysts also recently weighed in on the stock.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога